Navigation Links
Hill-Rom Reports First Quarter Revenue Growth of 3.0 Percent to $352 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.23, an Increase of 15.0 Percent From the Prior Year

BATESVILLE, Ind., Feb. 4 /PRNewswire-FirstCall/ -- Hill-Rom Holdings, Inc. (NYSE: HRC), announced unaudited financial results for its fiscal first quarter ended December 31, 2008. Results included revenue of $351.6 million, a $10.2 million or 3.0 percent increase from $341.4 million in the prior year comparable period. On a constant currency basis, revenue increased 5.9 percent. Net income from continuing operations was $14.2 million, or $0.23 per fully diluted share--an increase of 15.0 percent. Adjusted earnings per fully diluted share from continuing operations were $0.25, an increase of 13.6 percent from the prior year. Adjustments experienced in the current year include the effects of lower Liko margins associated with the valuation of acquired inventories and Liko integration costs. Adjustments in the prior year include costs associated with the planned spin-off of the funeral services business and special charges. Unless otherwise indicated, amounts in the current quarter include the results of Liko, acquired on October 1, 2008.

Management Comments

"As we reported last month, U.S. hospital customers made significant and rapid reductions of capital spending during the last half of the quarter on a wide variety of medical technologies, including ours. Because of our diverse portfolio, rental alternatives, the relative strength of our international business and the acquisition of Liko, we were better able to weather the storm in the first quarter," commented Peter H. Soderberg, president and CEO of Hill-Rom. "As we look forward, we believe U.S. hospitals will continue to reduce or postpone capital purchases as they respond to the effects of the economy on their operations; further, we anticipate that during the second half of the year we might begin to see signs in Europe of softening capital expenditures. All this has led us to update our guidance and present a more cautious outlook for the rest of 2009."

Soderberg continued, "During these difficult times, however, we remain committed to implementing our multi-year strategy that calls for continued investments in new product development, global strengthening of our field sales and clinical support team, supply chain efficiencies and continuous improvement to expand our operating margins. Reflecting our cost control actions, operating expenses declined 3.6 percent after excluding $7.9 million of Liko operating costs."

Commenting on the integration of Liko operations, Soderberg stated, "Liko posted sales of $18.4 million, in line with expectations. Our customers are responding well to this latest addition to our patient safety solutions portfolio in the area of safe lifting and mobilization."

Other first quarter revenue highlights regarding Hill-Rom business segments include:

-- North America Acute Care. Hill-Rom North America Acute Care revenue declined $7.8 million, or 3.7 percent, to $203.5 million. Capital sales decreased 8.3 percent, or $12.6 million, primarily driven by decreases in our patient support systems and architectural products. Despite this negative trend, healthcare information technology showed growth in excess of 20 percent due to the recent launch of the all digital NaviCare (R) Nurse Call system.

Rental revenue increased by $4.8 million, or 8.3 percent, during the quarter, due to higher volumes from new product fleet investments in bariatric and wound care and the impact of strategic adjustments made to our sales channel implemented over the last fiscal year.

-- International and Surgical. Hill-Rom International and Surgical capital and rental revenue increased $15.4 million, or 18.4 percent, to $98.9 million, principally driven by the acquisition of Liko and stronger performance of capital sales in Europe and Latin America. Constant currency growth was 28.0 percent, with approximately half related to the Liko acquisition. Capital sales increased $16.4 million, or 23.7 percent, while rental revenue declined by $1.0 million, or 7.2 percent.

-- North America Post-Acute Care. Hill-Rom North America Post-Acute Care revenue increased $2.3 million, or 4.8 percent, to $50.4 million. Capital sales revenue increased by $2.3 million, or 26.7 percent, primarily due to the Liko acquisition, sales channel initiatives and new product sales. Rental revenue was equivalent to the prior year at $39.5 million, with strong respiratory and home care performance offset by continued softness in extended care.

    Other Fourth Quarter Financial and Operational Highlights

    Gross Profit and Operating Expenses:

-- Hill-Rom gross profit was up slightly from the prior year to $152.5 million, although gross margin declined 110 basis points to 43.4 percent. Capital gross profit declined by 3.8 percent, and gross margin was down 260 basis points versus the prior year due to the reduced volume of North America acute patient support products along with higher growth of lower margin International sales. Capital margins were also negatively impacted by $1.9 million related to the valuation of acquired Liko inventories and a union ratification bonus of $0.9 million incurred in the quarter. Rental gross profit grew by 6.8 percent and associated gross margin improved 180 basis points, due primarily to increased revenue and cost improvement actions within the field service network.

-- Operating expenses as a percent of sales declined 20 basis points to 36.8 percent. General and administrative expenses declined by upper-single- digits, excluding Liko.

-- Cash flow from operations was $34.9 million for the first quarter. Strong collections of our receivables were offset by increases in inventory and the timing of liability payments. The increase in inventory was a direct result of the impact of reduced demand for capital products.

-- Income tax expense in the first quarter reflects an effective rate of 32.4 percent compared to 39.8 percent in the prior year period. The lower rate in the current year is related to the effect of more favorable foreign tax rates and higher discrete income tax benefits, most notably related to the retroactive reenactment of the research and development tax credit. The tax rate excluding these discrete items would have been 38.6 percent in the current period compared to 43.2 percent in the prior year.


-- On January 14, 2009, the company announced several cost savings actions taken as part of its strategic plan as well as additional measures taken in light of reduced sales volume of U.S. capital products. Actions taken included: 1) Consolidation of certain manufacturing and selected back office operations; 2) Redeployment of U.S. sales and service resources to increase our customer presence and support; 3) Further reduction in non-sales, non-R&D discretionary spending; 4) A voluntary early retirement program and 5) Involuntary job eliminations to reflect lower capital equipment demand and productivity improvements. It is anticipated that the eliminations and operational consolidations will result in approximately $12 to $14 million in annualized savings, about half of which is related to volume declines. Further, the company expects to incur a special charge related primarily to severance, early retirement benefits, and other personnel costs associated with the consolidation of certain operations of approximately $7 to $10 million over the second and possibly third quarters. There also will be additional special charges related to the impairment of assets, lease terminations, and pension and health care plan costs associated with these actions. These measures were implemented in addition to the previously described streamlining actions taken in August 2008.

On March 31, 2008, Hill-Rom completed the spin-off of its funeral services business operating under the Batesville Casket name. Accordingly, the results of operations of the funeral services business, including certain separation related costs and other income and expenses assigned to the funeral services business, have been presented as discontinued operations for all periods presented in the Condensed Consolidated Statements of Income.

Please see the attached schedules for additional information, including reconciliations of earnings in accordance with U.S. generally accepted accounting principles ("GAAP") to as adjusted income and earnings per share, condensed financial information, summary balance sheet information and segment sales summaries.

For a more complete review of Hill-Rom's results, please refer to our Quarterly Report on Form 10-Q for the quarter ended December 31, 2008, which will be filed later this week.

Financial Guidance Summary For 2009

Management is updating full year 2009 financial guidance initially provided on October 7, 2008 in conjunction with Hill-Rom's investor conference.

The fundamental change in our outlook relates to North America Acute Care capital sales and the impact of foreign exchange rates. Since late November the company has experienced a significant number of orders frozen due to hospital capital constraints. There is considerable uncertainty as to the depth and duration of future capital expenditure limitations; accordingly, the company's revised guidance is based on an estimated year-over-year reduction in North America Acute Care capital revenues of 15 to 30 percent. Our fiscal year outlook for the rest of our businesses remains essentially unchanged.

Hill-Rom's consolidated revenue guidance range for fiscal 2009 is expected to be $1.375 to $1.470 billion which represents a 2.5 to 8.8 percent reduction versus prior year. Earnings per fully diluted share from continuing operations are expected to be $0.66 to $1.05, with adjusted earnings per fully diluted share expected to be $0.82 to $1.18. Financial guidance in tabular format is included as an attachment.

Hill-Rom Holdings, Inc. provides earnings per share guidance on an adjusted basis from continuing operations because the company's management believes that the presentation provides useful information to investors. This measure excludes strategic developments, undetermined special charges and the impact of significant litigation. Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the company's reported operations for a period. Often, prospective quantification of such items is not feasible. Management uses these measures internally for planning, forecasting and evaluating the performance of the business, including evaluating results relative to employee performance compensation targets. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

Additional assumptions and discussion will be provided during the Company's conference call to be held tomorrow morning. Information to access the webcast is provided below.

Conference Call Replay and Webcast

The company will sponsor a conference call and webcast for the investing public at 8 a.m. EST, 7 a.m. CST, on Thursday, February 5, 2009. The webcast is available at or and will be archived on the company's website through February 4, 2010 for those who are unable to listen to the live webcast. A replay of the call is also available through February 12, 2009 at 888-203-1112 (719-457-0820 International). Code 7473680 is needed to access the replay.


Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

    Hill-Rom ... enhancing outcomes for patients and their caregivers.

Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward- looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward- looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's announced or future strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the recent spin-off of the funeral service business, failure to realize the anticipated benefits of the spin-off, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, adverse changes in global economic conditions or disruptions of credit markets, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended September 30, 2008 and the Quarterly Report on Form 10-Q for the quarter ended December 31, 2008, which will be filed later this week. The Company assumes no obligation to update or revise any forward-looking statements.

                             Hill-Rom Holdings, Inc.
                         Condensed Financial Information
                   (Dollars in millions except per share data)

     Condensed Statement of
     Earnings                      1Q09     4Q08     3Q08     2Q08     1Q08
    Net revenues
      Capital sales                $236.0   $309.3   $249.9   $255.3   $229.5
      Rental revenues               115.6    115.0    116.9    119.9    111.9
        Total revenues              351.6    424.3    366.8    375.2    341.4
    Cost of revenues
      Cost of goods sold            146.5    181.3    150.5    150.3    136.5
      Rental expenses                52.6     53.4     55.7     57.6     52.9
        Total cost of revenues      199.1    234.7    206.2    207.9    189.4
    Gross profit
      Capital sales                  89.5    128.0     99.4    105.0     93.0
      Rental revenues                63.0     61.6     61.2     62.3     59.0
        Total gross profit          152.5    189.6    160.6    167.3    152.0
    As a percentage of sales        43.4%    44.7%    43.8%    44.6%    44.5%

    Operating expense               129.5    133.4    137.3    146.9    126.3
    As a percentage of sales        36.8%    31.4%    37.4%    39.2%    37.0%

    Special charges                   -      (20.5)      -        -      (2.3)

    Operating profit                 23.0     35.7     23.3     20.4     23.4

    Other income/(expense), net      (2.0)    (2.9)    (1.3)    (3.5)    (2.8)

    Income tax expense (1)            6.8      9.0      0.5      7.5      8.2

    Income from continuing
     operations                     $14.2    $23.8    $21.5     $9.4    $12.4

    Diluted earnings per share:
      Earnings per share from
       continuing operations        $0.23    $0.38    $0.34    $0.15    $0.20

    Average common shares
     outstanding  - diluted
     (thousands)                   62,808   62,734   62,655   62,566   62,403

    Dividends per common share    $0.1025  $0.1025  $0.1025  $0.2850  $0.2850

    Consolidated Cash Flows from
     Operations (2)
      Cash flow from operations     $34.9    $43.3    $23.0    $84.1   $120.1
      Less: capital expenditures    (13.6)   (25.3)   (20.6)   (30.7)   (26.0)
      Consolidated free cash flow   $21.3    $18.0     $2.4    $53.4    $94.1

      Cash and cash equivalents     $49.5   $221.7   $131.2   $145.9   $125.5
      Investment securities (3)     $38.1    $44.9    $46.2    $48.6   $164.3

    Hill-Rom Capital Expenditures   $13.6    $25.3    $20.6    $28.7    $23.7
    Hill-Rom Depreciation &
     Amortization                   $26.1    $28.1    $25.5    $25.5    $24.4

    (1) For fiscal year 2008, discrete tax benefits totaled $8.3 million
        ($0.13 per share), $7.8 million ($0.12 per share) of which was
        recognized in the third fiscal quarter, principally associated with
        the release of valuation allowances on foreign tax credit
        carryforwards and the recognition of certain previously unrecognized
        tax benefits associated with recently completed tax audits. Discrete
        tax benefits of $1.3 million were recognized in the first quarter of
        fiscal 2009, most notably related to the retroactive reinstatement
        of the research and development tax credit, compared to $0.7 million
        in the prior year comparable period.

    (2) Consolidated cash flow amounts are "as reported" and thus include
        cash flows from the funeral services business through March 31,

    (3) Beginning June 30, 2008, investment securities were classified as
        long term assets on the balance sheet.

    Consolidated Results - Highlights

    Revenues - Constant Currency

    ($ In Millions)                 Q1     Y/Y       Q1      Q1      Adj/
                                   2009  Foreign    2009    2008    Actual
                                  Actual Exchange Adjusted Actual  % Change

    Acute Care                    $203.5    $2.1   $205.6   $211.3    -2.7%
    Post Acute Care                 50.4      -      50.4     48.1     4.8%
    International and Surgical      98.9     8.0    106.9     83.5    28.0%
    Eliminations                    (1.2)     -      (1.2)    (1.5)  -20.0%
    Total                         $351.6   $10.1   $361.7   $341.4     5.9%

    Non-GAAP Financial Disclosures and Reconciliations

While Hill-Rom reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Hill-Rom uses the non-GAAP measures to evaluate and manage its operations and provides the information to assist investors in performing financial analysis that is consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

                                  Income from              Income from
                                   Continuing               Continuing
                                Operations - 2009        Operations - 2008

                                      Income Diluted            Income Diluted
    First Quarter            Pre-tax   Taxes   EPS     Pre-tax   Taxes   EPS

    Income from continuing
     operations - GAAP        $21.0    $6.8    $0.23    $20.6    $8.2    $0.20
      Effect of Liko inventory
       valuation                1.9     0.5     0.02     -        -       -
      Liko acquisition
       integration charges      0.3     0.1     -        -        -       -
      Special charges           -       -       -         2.3     0.9     0.02
      Separation costs          -       -       -         0.1     -       -

    Income from continuing
     operations - Adjusted    $23.2    $7.4    $0.25    $23.0    $9.1    $0.22

    Note:  Certain per share amounts may not accurately add due to rounding.

Note: Earnings in the above presentation of adjusted income from continuing operations have not been adjusted to remove the effects of discrete period tax adjustments recognized in any of the periods presented. Discrete period tax adjustments are routinely recognized throughout any given year under a variety of circumstances and are highly subjective in nature. In the first quarter of fiscal 2009, discrete tax benefits totaled $1.3 million compared to $0.7 million in the prior year comparable period.

    Selected Summary Balance Sheet Schedule

                                         12/31/2008   9/30/2008
    Current Assets
       Cash and cash equivalents             $49.5      $221.7
       Trade accounts receivable, net of
        allowances                           348.8       395.1
       Inventories                           127.3       100.0
       Other current assets                   50.1        55.5
          Total current assets               575.7       772.3

    Equipment leased to others, net          164.3       171.4
    Property, net                            124.9       125.4
    Goodwill                                 539.1       422.5
    Other assets                             221.4       198.3

       Total Assets                       $1,625.4    $1,689.9

    Current Liabilities
       Trade accounts payable                $80.7       $99.4
       Short-term borrowings                 122.0       122.6
       Other current liabilities             144.3       172.7
          Total current liabilities          347.0       394.7

    Long-term debt                           100.8       100.2
    Other long-term liabilities              115.4       112.4

       Total Liabilities                     563.2       607.3

    Shareholders' Equity                   1,062.2     1,082.6

    Total Liabilities and Shareholders'
     Equity                               $1,625.4    $1,689.9

       Financial Guidance for Fiscal Year 2009

                                               Actual           2009 Range
        ($ in millions, except EPS)              2008         Low        High

       Net Revenues
         Capital sales                         $1,044        $905        $986
         Rental revenues                          464         470         484
       Total revenues                           1,508       1,375       1,470
           YoY % Change                         11.1%       -8.8%       -2.5%

         Capital sales gross margin %           40.7%       40.3%       41.3%
         Rental revenues gross margin %         52.6%       52.8%       53.5%
         Total gross margin %                   44.4%       44.6%       45.4%

       Other operating expenses                   537         531         550
       Special charges and other items
        (see below)                                31          12           9

       Operating Profit                           103          70         108
       Other income / (expense)                   (10)         (8)         (8)
       Income from Continuing Operations
        before Income Taxes                        93          62         100

       Tax Rate                                 27.3%       32.0%       34.0%

       Income from Continuing Operations          $67         $42         $66

       Earnings per share - GAAP                $1.07       $0.66       $1.05
       Separation costs                          0.02         -           -
       Special charges (1)                       0.22        0.10        0.07
       Stock modification charge                 0.06         -           -
       Loss on extinguishment of debt            0.03         -           -
       Liko acquisition inventory step-up         -          0.04        0.04
       Liko acquisition integration
        charges                                   -          0.02        0.02

       Earnings per share - Adjusted (2)        $1.40       $0.82       $1.18

    (1)  Special charges in fiscal 2009 include the range of disclosed charges
         associated with restructuring actions announced by us on January 14,
         2009. This range does not include additional yet to be quantified
         charges related to the impairment of assets, lease terminations and
         pension and health care plan costs associated with these actions.

    (2)  Earnings per share - Adjusted in the above presentation have not been
         adjusted to remove the effects of discrete period tax adjustments
         recognized in any of the periods presented. Discrete period tax
         adjustments are routinely recognized throughout any given year under
         a variety of circumstances and are highly subjective in nature. For
         fiscal year 2008, discrete tax benefits totaled $8.3 million ($0.13
         per share), while year-to-date discrete tax benefits in fiscal 2009
         totaled $1.3 million ($0.02 per share).

SOURCE Hill-Rom Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds
2. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast
3. Hill-Rom Reports First Quarter Revenue of $350 Million and Announces Further Actions to Address Challenging Economic Environment
4. JCR, Hill-Rom Launch Nurse Safety Scholar-in-Residence Program
5. Hill-Rom Announces First Quarter 2009 Dividend
6. Hill-Rom Wins Gold Brandon Hall Learning Award
7. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast
8. Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames
9. Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year
10. Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast
11. Hill-Rom Announces Agreement With Tri-anim to Enhance Distribution Channels for The Vest(R) System in U.S. Hospitals & Long-Term Care Facilities
Post Your Comments:
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/4/2017)... 2017  According to the Centers for Disease Control and Prevention (CDC), ... PhysicianOne Urgent Care is helping communities across Massachusetts , ... by offering no-cost* flu shots through the end of the month. ... insurance regulations. ... get a flu shot is by the end of October, according to ...
Breaking Medicine Technology: